A recent study published in Marine Drugs (2025) sheds light on the bioactive compounds and chemodiversity of tropical brown macroalgae, highlighting their potential as a sustainable source for pharmaceuticals, nutraceuticals, and functional food products. Brown macroalgae are rich in unique compounds such as phlorotannins, fucoxanthin, and sulfated polysaccharides, which exhibit antioxidant, anti-inflammatory, and antimicrobial properties .
The research emphasizes the importance of conserving marine biodiversity while promoting the utilization of seaweed resources in tropical regions. By mapping chemodiversity and bioactivity, the study provides valuable insights for developing innovative marine-based products that align with global sustainability efforts. This contributes directly to the United Nations Sustainable Development Goals (SDG 3 – Good Health and Well-being, SDG 12 – Responsible Consumption and Production, SDG 14 – Life Below Water, SDG 15 – Life on Land).
Full article: https://ejabf.journals.ekb.eg/article_418563.html
Meet the Researchers:
This study was conducted by Safri Ishmayana, Mostefa Fodil, Danang A. Prabowo, Diah R. Noerdjito, Debora C. Purbani, Varian Fahmi, Wiwin Natalia, Ronny Lesmana, Mochamad F.A. Ismail, Ankiq Taofiqurohman, Ibnu Faizal, Muhammad Yusuf, Sulastri Arsad, Nia Rossiana, Jean-Luc Mouget, and Fiddy S. Prasetiya from Universitas Padjadjaran, Le Mans Université (France), BRIN, Universitas Brawijaya, and collaborating research centers.
Hashtags:
#MarineBiotechnology #BrownMacroalgae #BioactiveCompounds #SustainableOceans #UnpadResearch #SDG3 #SDG12 #SDG14 #SDG15